Peter Lawson

Stock Analyst at Barclays

(1.34)

# 3,282

Out of 4,827 analysts

104

Total ratings

37.8%

Success rate

-14.33%

Average return

Main Sectors:

Top Industries:

Biotechnology Diagnostics & Research

Stocks Rated by Peter Lawson

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KURA Kura Oncology	Maintains: Overweight	$32 → $11	$6.03	+82.42%	1	May 2, 2025
	ARVN Arvinas	Maintains: Overweight	$32 → $16	$6.77	+136.34%	8	May 2, 2025
	BCYC Bicycle Therapeutics	Maintains: Overweight	$40 → $15	$8.12	+84.73%	2	May 1, 2025
	SWTX SpringWorks Therapeutics	Downgrades: Equal-Weight	$63 → $47	$46.18	+1.79%	4	Apr 28, 2025
	RCUS Arcus Biosciences	Maintains: Overweight	$29 → $14	$8.30	+68.67%	7	Apr 23, 2025
	IOVA Iovance Biotherapeutics	Maintains: Overweight	$22 → $5	$3.29	+52.21%	6	Apr 14, 2025
	BMEA Biomea Fusion	Maintains: Equal-Weight	$11 → $3	$1.78	+68.54%	5	Apr 2, 2025
	TCRX TScan Therapeutics	Maintains: Overweight	$14 → $3	$1.42	+111.27%	2	Mar 7, 2025
	GERN Geron	Maintains: Overweight	$9 → $4	$1.31	+206.51%	1	Feb 27, 2025
	EXEL Exelixis	Maintains: Equal-Weight	$25 → $29	$36.64	-20.85%	5	Feb 13, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$54 → $60	$41.79	+43.59%	3	Sep 27, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$14 → $17	$3.04	+459.21%	5	Sep 10, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$32 → $33	$11.04	+198.91%	4	Aug 15, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$92 → $66	$29.57	+123.20%	2	Aug 9, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$9 → $8	$1.54	+421.17%	8	Jul 31, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Equal-Weight	$75 → $105	$100.01	+4.99%	10	Jul 29, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$20 → $31	$9.84	+215.04%	2	Jul 15, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$13 → $17	$7.92	+114.65%	3	Jun 7, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$18 → $13	$1.15	+1,030.43%	1	May 24, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$6 → $10	$1.05	+852.38%	3	Feb 27, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Underweight	$2 → $1	$0.30	+231.13%	2	Aug 10, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Equal-Weight	$7 → $5	$0.78	+538.57%	4	Aug 4, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$210 → $120	$6.16	+1,849.63%	2	Aug 5, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$7 → $3.5	$1.16	+201.72%	4	Jul 7, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Underweight	$355 → $365	$80.55	+353.13%	1	Aug 6, 2021
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgrades: Overweight	$46	$28.64	+60.61%	2	Oct 22, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Underweight	$28	$9.02	+210.42%	1	Mar 4, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Overweight	$30	$0.61	+4,834.21%	1	Mar 4, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgrades: Buy	$17 → $45	$1.45	+3,003.45%	2	Jan 23, 2018
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgrades: Buy	$16 → $45	$36.60	+22.95%	2	Jan 23, 2018
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Buy	$70	$0.70	+9,900.00%	1	Jul 14, 2017

Kura Oncology

May 2, 2025

Maintains: Overweight

Price Target: $32 → $11

Current: $6.03

Upside: +82.42%

Arvinas

May 2, 2025

Maintains: Overweight

Price Target: $32 → $16

Current: $6.77

Upside: +136.34%

Bicycle Therapeutics

May 1, 2025

Maintains: Overweight

Price Target: $40 → $15

Current: $8.12

Upside: +84.73%

SpringWorks Therapeutics

Apr 28, 2025

Downgrades: Equal-Weight

Price Target: $63 → $47

Current: $46.18

Upside: +1.79%

Arcus Biosciences

Apr 23, 2025

Maintains: Overweight

Price Target: $29 → $14

Current: $8.30

Upside: +68.67%

Iovance Biotherapeutics

Apr 14, 2025

Maintains: Overweight

Price Target: $22 → $5

Current: $3.29

Upside: +52.21%

Biomea Fusion

Apr 2, 2025

Maintains: Equal-Weight

Price Target: $11 → $3

Current: $1.78

Upside: +68.54%

TScan Therapeutics

Mar 7, 2025

Maintains: Overweight

Price Target: $14 → $3

Current: $1.42

Upside: +111.27%

Geron

Feb 27, 2025

Maintains: Overweight

Price Target: $9 → $4

Current: $1.31

Upside: +206.51%

Exelixis

Feb 13, 2025

Maintains: Equal-Weight

Price Target: $25 → $29

Current: $36.64

Upside: -20.85%

Sep 27, 2024

Maintains: Overweight

Price Target: $54 → $60

Current: $41.79

Upside: +43.59%

Sep 10, 2024

Maintains: Overweight

Price Target: $14 → $17

Current: $3.04

Upside: +459.21%

Aug 15, 2024

Maintains: Overweight

Price Target: $32 → $33

Current: $11.04

Upside: +198.91%

Aug 9, 2024

Maintains: Overweight

Price Target: $92 → $66

Current: $29.57

Upside: +123.20%

Jul 31, 2024

Maintains: Overweight

Price Target: $9 → $8

Current: $1.54

Upside: +421.17%

Jul 29, 2024

Maintains: Equal-Weight

Price Target: $75 → $105

Current: $100.01

Upside: +4.99%

Jul 15, 2024

Maintains: Overweight

Price Target: $20 → $31

Current: $9.84

Upside: +215.04%

Jun 7, 2024

Maintains: Overweight

Price Target: $13 → $17

Current: $7.92

Upside: +114.65%

May 24, 2024

Maintains: Overweight

Price Target: $18 → $13

Current: $1.15

Upside: +1,030.43%

Feb 27, 2024

Maintains: Overweight

Price Target: $6 → $10

Current: $1.05

Upside: +852.38%

Aug 10, 2023

Maintains: Underweight

Price Target: $2 → $1

Current: $0.30

Upside: +231.13%

Aug 4, 2023

Maintains: Equal-Weight

Price Target: $7 → $5

Current: $0.78

Upside: +538.57%

Aug 5, 2022

Maintains: Overweight

Price Target: $210 → $120

Current: $6.16

Upside: +1,849.63%

Jul 7, 2022

Maintains: Overweight

Price Target: $7 → $3.5

Current: $1.16

Upside: +201.72%

Aug 6, 2021

Maintains: Underweight

Price Target: $355 → $365

Current: $80.55

Upside: +353.13%

Oct 22, 2020

Upgrades: Overweight

Price Target: $46

Current: $28.64

Upside: +60.61%

Mar 4, 2020

Initiates: Underweight

Price Target: $28

Current: $9.02

Upside: +210.42%

Mar 4, 2020

Initiates: Overweight

Price Target: $30

Current: $0.61

Upside: +4,834.21%

Jan 23, 2018

Upgrades: Buy

Price Target: $17 → $45

Current: $1.45

Upside: +3,003.45%

Jan 23, 2018

Upgrades: Buy

Price Target: $16 → $45

Current: $36.60

Upside: +22.95%

Jul 14, 2017

Initiates: Buy

Price Target: $70

Current: $0.70

Upside: +9,900.00%